medline.ch Neurologie Multiple Sklerose

	Abuse in individuals with multiple sclerosis: the SocialMS Italian study. Mult Scler Relat Disord Ponzano M, Signori A, Schiavetti I, Landi D, Bellavia A, Lavorgna L, Fantozzi R, Buttari F, Di Sapio A, Malucchi S, Marinelli F, Battaglia MA, Vercellino M, Callari G, Frau J, Marfia GA, Tsantes E, Grasso MG, Surcinelli A, Zuliani L, Cordioli C, Sinisi L, Clerici R, Immovilli P, Stromillo ML, Mori L, Laroni A, Lanzillo R, Lugaresi A, Sormani MP, SocialMS study group. PMID: 41719899 [PubMed - as supplied by publisher]
	Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study. Neurol Neuroimmunol Neuroinflamm Blant JC, De Rossi N, Gold R, Maurousset A, Kraemer M, Romero-Pinel L, Misu T, Ouallet JC, Pallix Guyot M, Gerevini S, Bakirtzis C, Piñar Morales R, Vlad B, Karypidis P, Moisset X, Derfuss TJ, Jelcic I, Martin-Blondel G, Ayzenberg I, McGraw C, Laplaud DA, Lebrun-Frenay C, Du Pasquier RA, Bernard-Valnet R, CORPUS and Italian PML study groups. PMID: 41719500 [PubMed - indexed for MEDLINE]
	Tolebrutinib Phase 2b Long-Term Extension Study: Two-Year Safety, MRI, and Clinical Efficacy Outcomes in Patients With Relapsing Multiple Sclerosis Patients. Neurol Open Access Oh J, Fox RJ, Arnold DL, Syed S, Dukovic D, Vargas WS, Turner TJ, Underwood CF, Long TM, Traboulsee AL, Reich DS. PMID: 41717535 [PubMed]
	TMS-EEG signatures of motor network dysfunction in multiple sclerosis. Brain Commun Leodori G, Mancuso M, Maccarrone D, Tartaglia M, De Bartolo MI, Collura A, Pellegrini S, Malimpensa L, Belvisi D, Ferrazzano G, Ziemann U, Conte A. PMID: 41717136 [PubMed]
	Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis. Front Neurol Taluntiene V, Giedraitiene N, Kizlaitiene R, Vaisvilas M, Kaubrys G. PMID: 41716551 [PubMed]
	Association of Neurodevelopmental Disorders and Congenital Anomalies With Prenatal Multiple Sclerosis Treatment-Real-World Historical Cohort Study. Clin Pharmacol Ther Rosh B, Levi O, Stein N, Yahav A, Gronich N. PMID: 41715957 [PubMed - as supplied by publisher]
	Radiomics and Artificial Intelligence in Multiple Sclerosis MRI: A Comprehensive Review. AJNR Am J Neuroradiol Petrou K, Ploussi A, Seimenis I, Karavasilis E, Velonakis G, Efstathopoulos EP. PMID: 41714129 [PubMed - as supplied by publisher]
	A longitudinal study of depression, anxiety, and disability in multiple sclerosis: Profile and trajectories analyses. J Affect Disord Aloni R, Peretz O, Koren M. PMID: 41713613 [PubMed - as supplied by publisher]
	Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment tool. Mult Scler Relat Disord Jackson DA, Bergmann CS, Wilken J, Weller J, Zarif M, Bumstead B, Buhse M, Jo M, Barrera MA, Penner IK, Morrow SA, Hancock LM, Bogaardt H, Covey TJ, Doniger GM, Golan D, Gudesblatt M. PMID: 41713333 [PubMed - as supplied by publisher]
	Prevalence and factors associated with polypharmacy among people with multiple sclerosis (PwMS) receiving outpatient rehabilitation: A cross-sectional study. Mult Scler Relat Disord Feng G, Scandiffio J, Law V, Oh J, Bayley M, Simpson R. PMID: 41713332 [PubMed - as supplied by publisher]
	Editorial for "Association Between Intermittent Fasting and Susceptibility-Weighted MRI Phase Values in Deep Gray Matter of Patients With Multiple Sclerosis: An Observational Cohort Study". J Magn Reson Imaging So TY, Chen W. PMID: 41711593 [PubMed - as supplied by publisher]
	Impact of whole-body vibration training on gait in patients with progressive multiple sclerosis: a pilot randomised study. BMJ Neurol Open Konitsioti AM, Göreci Y, Hellmich M, Schweitzer F, Blaschke S, Golla H, Waßner L, Stolzenberger J, Fink GR, Schroeter M, Schoenau E, Stark C, Warnke C. PMID: 41710925 [PubMed]
	Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China. BMC Neurol Tan H, Zhou L, Gao Y, Zhao C, Lu C, Dong Q, ZhangBao J, Quan C. PMID: 41709182 [PubMed - as supplied by publisher]
	Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1). CNS Drugs Bejarano I, Jiménez-Jorge S, Lobo-Acosta MÁ, Álvarez-López AI, Rosso-Fernández CM, López-Ruiz R, Eichau S, Ruiz-Peña JL, Géniz MÁ, Ampuero J, Ponce-España E, Merino-Bohorquez V, Cameán M, García-Sánchez MI, Izquierdo G, Guerrero JM, Romero-Gómez M, Lardone PJ, Carrillo-Vico A. PMID: 41706381 [PubMed - as supplied by publisher]
	Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE Study. Neurol Ther Pilotto S, Ghezzi A, Bova SM, Fronza M, Annovazzi P, Simone M, Gallo A, Suppiej A, Lanzillo R, Rasia S, Berardinelli A, Torri Clerici V, Moiola L, Viri M, Sotgiu S, Malucchi S, Protti A, Canavese C, Lus G, Grimaldi L, Conti MZ, Borriello G, De Luca G, Tomassini V, Priori A, Tosi M, Pomella N, Corona A, Zollo A, Amato MP, Cocco E, Trojano M, Martinelli-Boneschi F, D'Alfonso S, Bergamaschi R, Pugliatti M, PEDIGREE Study Group. PMID: 41706361 [PubMed - as supplied by publisher]
	GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial. Mult Scler Miller A, Cohen JA, Karni A, Popper L, Bleich Kimelman N, Rubnov S, Danon U, Marom E, Boyko A, Zivadinov R, Berger JR, Bar-Or A, Kolb H. PMID: 41705515 [PubMed - indexed for MEDLINE]
	Impact of preanalytical factors on blood CHI3L1 levels. Front Immunol Comabella M, Gutierrez L, Castillo M, Villar LM, Eixarch H, La Puma D, Aroca M, Vilaseca A, Montalban X, Fissolo N. PMID: 41704533 [PubMed - indexed for MEDLINE]
	BTK inhibitors in multiple sclerosis: emerging evidence and future directions. Expert Opin Pharmacother Zanetta C, Rocca MA, Filippi M. PMID: 41704027 [PubMed - as supplied by publisher]
	The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms. Mol Neurobiol Bucciero C, Croce A, Castellano G, Beguinot F, Formisano P, Portella G, Ulianich L, Fiory F, Malfitano AM. PMID: 41703223 [PubMed - indexed for MEDLINE]
	A randomised controlled trial of internet-delivered cognitive behavioural therapy targeting symptoms of depression, anxiety and disability in adults with multiple sclerosis. J Affect Disord Gandy M, Wu W, Balakumar T, Francis H, Oxenham V, Bisby MA, Titov N, Dear BF. PMID: 41702459 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 43367

Seite 1 von 2169

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung